We use essential cookies to make this website work and to help improve it for you.
Change website language
Cymraeg – Newid yr iaith ir Gymraeg
English
Home
The International Horizon Scanning and Learning work stream was initiated as a product of, and to inform upon, the evolving COVID-19 public health response and recovery plans in Wales. It […]
Published on: 21st May 2020
Category: Evidence and research, International Health Insights
Sharing the stories of individuals who have made a remarkable difference to those affected by adverse childhood experiences (ACEs).
Published on: 20th May 2020
Category: Case study
Published on: 14th May 2020
Published on: 7th May 2020
Category: Evidence and research, International Health Insights, Literature review
This strategy has been developed by the Wales Violence Prevention Unit. It is designed as a framework for the prevention of serious youth violence in South Wales. The primary audience […]
Published on: 30th April 2020
Category: Strategy
This report aims to bring together what we know about ACEs in refugee and asylum seeking children arriving and settling into host countries, highlighting their nature, extent and impact. View […]
Published on: 23rd April 2020
Category: Data and analysis
The pan-Wales Early Action Together (E.A.T.) programme aimed to develop a whole systems response to vulnerability to enable police and multi-agency (MA) partners to recognise signs of vulnerability at the […]
Published on: 15th April 2020
Category: Evidence and research
Philtre is the monthly bulletin of WEDINOS. It provides monthly summaries of drug analysis results, emerging substance trends, and harm reduction information. This bulletin serves as a vital resource for […]
Published on: 1st April 2020
This report dated April 2020 provides a comprehensive yearly summary of the samples analysed by WEDINOS/Philtre, highlighting key trends, statistical data, and public health implications. This report offers a broad […]
Background The pneumococcal polysaccharide vaccination (PPV) is currently offered to those aged 65 years and over and people aged two to 64 years in select clinical risk groups. PPV protects […]
Published on: 31st March 2020